EP 1545591 A2 20050629 - THERAPEUTIC USE FOR LP229, IN PARTICULAR FOR WOUND HEALING
Title (en)
THERAPEUTIC USE FOR LP229, IN PARTICULAR FOR WOUND HEALING
Title (de)
THERAPEUTISCHE VERWENDUNG VON LP229, INSBESONDERE ZUR WUNDHEILUNG
Title (fr)
UTILISATION THERAPEUTIQUS DE LP229 POUR TRAITER LES BLESSURES
Publication
Application
Priority
- US 0200487 W 20020109
- US 26245801 P 20010118
- US 32523301 P 20010927
Abstract (en)
[origin: WO03065981A2] Methods of use are provided for the treatment or prevention of poor healing or chronic wounds, skin diseases, sepsis, inflammation, immunodeficiencies, autoimmune diseases, infectious diseases, allergic diseases, and malignancies, particularly those disorders associated with the skin, by administering an LP229 polypeptide, protein, or epitope-recognizing antibody thereof to a patient in need of such therapy.
IPC 1-7
IPC 8 full level
A61K 38/17 (2006.01); A61P 1/04 (2006.01); A61P 17/02 (2006.01); C07K 16/38 (2006.01)
CPC (source: EP)
A61K 38/1709 (2013.01); A61P 1/04 (2017.12); A61P 17/02 (2017.12); C07K 16/38 (2013.01)
Citation (search report)
See references of WO 03065981A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 03065981 A2 20030814; WO 03065981 A3 20050407; AU 2002365236 A1 20030902; AU 2002365236 A8 20030902; EP 1545591 A2 20050629
DOCDB simple family (application)
US 0200487 W 20020109; AU 2002365236 A 20020109; EP 02805684 A 20020109